Greenberg Traurig Attorneys David J. Dykeman and Christiana C. Jacxsens to Speak at DeviceTalks Boston

Share Article

David J. Dykeman and Christiana C. Jacxsens, shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks Boston, Sept. 28, 2016, at the Boston Marriott Long Wharf.

David J. Dykeman and Christiana C. Jacxsens, shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks Boston, Sept. 28, 2016, at the Boston Marriott Long Wharf. Greenberg Traurig is a founding sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011.

From 4:30 – 6:15 p.m., Dykeman, patent attorney, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and co-chair of the firm’s Intellectual Property (IP) Group in Boston, will moderate the Executive Track panel discussion, “Hot Topics: M&A, IP, Financing and Products Liability Trends Impacting MedTech Companies.” He will be joined by Jacxsens, Atlanta shareholder in Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Group; Dr. Omar Amirana, Senior Vice President, Allied Minds; Jeff Mann, Senior Managing Counsel, Med-Surg at Boston Scientific; Martha Shaddan, CEO, Rotation Medical; and Patrick West, Partner, Mirus Capital.

Specific topics include:

  •     M&A trends from the perspective of both acquirer and seller
  •     IP protection is key to a successful exit
  •     Financing best practices from early stage to exit
  •     Products liability litigation - what every medtech company needs to know

Hosted by online journal MassDevice.com, DeviceTalks is a conversation among leaders. It’s an evening for an exchange of ideas, insight, and contacts among the pioneers of the medical technology industry. Formerly known as the Big 100, this event is held annually in Boston, Orange County, Raleigh and the Twin Cities.

About Greenberg Traurig’s Life Sciences & Medical Technology Group

Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2,000 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No. 1 on the 2015 Law360 Most Charitable Firms list, third largest in the U.S. on the 2015 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2015 BTI Brand Elite. More information at: http://www.gtlaw.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website